vs
Side-by-side financial comparison of Emerald Holding, Inc. (EEX) and USANA HEALTH SCIENCES INC (USNA). Click either name above to swap in a different company.
USANA HEALTH SCIENCES INC is the larger business by last-quarter revenue ($250.2M vs $132.7M, roughly 1.9× Emerald Holding, Inc.). USANA HEALTH SCIENCES INC runs the higher net margin — 3.0% vs -22.8%, a 25.8% gap on every dollar of revenue. On growth, Emerald Holding, Inc. posted the faster year-over-year revenue change (24.3% vs -3.0%). Over the past eight quarters, USANA HEALTH SCIENCES INC's revenue compounded faster (11.8% CAGR vs -0.3%).
TVS Emerald Haven Realty Limited is an Indian real estate development company headquartered in Chennai, Tamil Nadu. A subsidiary of TVS Holdings, it specializes in sustainable residential communities and urban development projects.
Usana Health Sciences, Inc., or USANA, is an American multi-level marketing company based in Salt Lake City, Utah. As of 2021, Usana was the 14th largest direct-selling company in the world by revenue. The company manufactures most of its nutritional products, dietary supplements, and skincare products at a Salt Lake City facility. Its products are sold in 24 countries via a network of independent distributors.
EEX vs USNA — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2027
| Metric | | |
|---|---|---|
| Revenue | $132.7M | $250.2M |
| Net Profit | $-30.2M | $7.5M |
| Gross Margin | — | 76.2% |
| Operating Margin | -11.8% | 5.5% |
| Net Margin | -22.8% | 3.0% |
| Revenue YoY | 24.3% | -3.0% |
| Net Profit YoY | -692.2% | -20.0% |
| EPS (diluted) | $-0.15 | $0.41 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $250.2M | ||
| Q4 25 | $132.7M | $226.2M | ||
| Q3 25 | $77.5M | $213.7M | ||
| Q2 25 | $105.5M | $235.8M | ||
| Q1 25 | $147.7M | $249.5M | ||
| Q4 24 | $106.8M | $213.6M | ||
| Q3 24 | $72.6M | $200.2M | ||
| Q2 24 | $86.0M | — |
| Q1 26 | — | $7.5M | ||
| Q4 25 | $-30.2M | $180.0K | ||
| Q3 25 | $-14.4M | $-6.5M | ||
| Q2 25 | $-1.4M | $9.7M | ||
| Q1 25 | $15.3M | $9.4M | ||
| Q4 24 | $5.1M | $4.5M | ||
| Q3 24 | $-11.1M | $10.6M | ||
| Q2 24 | $-2.8M | — |
| Q1 26 | — | 76.2% | ||
| Q4 25 | — | 78.2% | ||
| Q3 25 | — | 77.2% | ||
| Q2 25 | — | 78.7% | ||
| Q1 25 | — | 79.0% | ||
| Q4 24 | — | 82.0% | ||
| Q3 24 | — | 80.4% | ||
| Q2 24 | — | — |
| Q1 26 | — | 5.5% | ||
| Q4 25 | -11.8% | 1.7% | ||
| Q3 25 | -10.1% | 0.6% | ||
| Q2 25 | 9.7% | 7.1% | ||
| Q1 25 | 24.2% | 6.3% | ||
| Q4 24 | 19.5% | 3.8% | ||
| Q3 24 | -6.5% | 7.8% | ||
| Q2 24 | 7.4% | — |
| Q1 26 | — | 3.0% | ||
| Q4 25 | -22.8% | 0.1% | ||
| Q3 25 | -18.6% | -3.1% | ||
| Q2 25 | -1.3% | 4.1% | ||
| Q1 25 | 10.4% | 3.8% | ||
| Q4 24 | 4.8% | 2.1% | ||
| Q3 24 | -15.3% | 5.3% | ||
| Q2 24 | -3.3% | — |
| Q1 26 | — | $0.41 | ||
| Q4 25 | $-0.15 | $-0.10 | ||
| Q3 25 | $-0.07 | $-0.36 | ||
| Q2 25 | $-0.01 | $0.52 | ||
| Q1 25 | $0.08 | $0.49 | ||
| Q4 24 | $0.01 | $0.23 | ||
| Q3 24 | $-0.05 | $0.56 | ||
| Q2 24 | $-0.03 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $100.9M | $162.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $338.8M | — |
| Total Assets | $1.2B | $739.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $162.8M | ||
| Q4 25 | $100.9M | $158.4M | ||
| Q3 25 | $95.4M | $145.3M | ||
| Q2 25 | $156.4M | $151.3M | ||
| Q1 25 | $276.8M | $179.6M | ||
| Q4 24 | $194.8M | $181.8M | ||
| Q3 24 | $188.9M | $364.9M | ||
| Q2 24 | $193.2M | — |
| Q1 26 | — | — | ||
| Q4 25 | $338.8M | — | ||
| Q3 25 | $369.5M | $528.1M | ||
| Q2 25 | $389.4M | $531.1M | ||
| Q1 25 | $392.1M | $529.8M | ||
| Q4 24 | $385.9M | $532.1M | ||
| Q3 24 | $391.1M | $533.1M | ||
| Q2 24 | $407.6M | — |
| Q1 26 | — | $739.0M | ||
| Q4 25 | $1.2B | $742.9M | ||
| Q3 25 | $1.2B | $726.6M | ||
| Q2 25 | $1.2B | $734.5M | ||
| Q1 25 | $1.2B | $746.6M | ||
| Q4 24 | $1.0B | $748.2M | ||
| Q3 24 | $1.1B | $671.3M | ||
| Q2 24 | $1.1B | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $12.3M | — |
| Free Cash FlowOCF − Capex | $11.7M | — |
| FCF MarginFCF / Revenue | 8.8% | — |
| Capex IntensityCapex / Revenue | 0.5% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $41.4M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $12.3M | — | ||
| Q3 25 | $1.8M | $-2.0M | ||
| Q2 25 | $15.9M | $12.2M | ||
| Q1 25 | $12.6M | $15.5M | ||
| Q4 24 | $20.6M | $5.8M | ||
| Q3 24 | $9.1M | $29.5M | ||
| Q2 24 | $9.8M | — |
| Q1 26 | — | — | ||
| Q4 25 | $11.7M | — | ||
| Q3 25 | $1.5M | $-5.2M | ||
| Q2 25 | $15.8M | $7.2M | ||
| Q1 25 | $12.4M | $12.7M | ||
| Q4 24 | $19.9M | $4.0M | ||
| Q3 24 | $9.0M | $27.1M | ||
| Q2 24 | $9.6M | — |
| Q1 26 | — | — | ||
| Q4 25 | 8.8% | — | ||
| Q3 25 | 1.9% | -2.4% | ||
| Q2 25 | 15.0% | 3.0% | ||
| Q1 25 | 8.4% | 5.1% | ||
| Q4 24 | 18.6% | 1.9% | ||
| Q3 24 | 12.4% | 13.6% | ||
| Q2 24 | 11.2% | — |
| Q1 26 | — | — | ||
| Q4 25 | 0.5% | — | ||
| Q3 25 | 0.4% | 1.5% | ||
| Q2 25 | 0.1% | 2.1% | ||
| Q1 25 | 0.1% | 1.1% | ||
| Q4 24 | 0.7% | 0.8% | ||
| Q3 24 | 0.1% | 1.2% | ||
| Q2 24 | 0.2% | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 1.27× | ||
| Q1 25 | 0.82× | 1.65× | ||
| Q4 24 | 4.04× | 1.29× | ||
| Q3 24 | — | 2.78× | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EEX
| Connections Segment | $121.9M | 92% |
| Commerce Segment | $5.5M | 4% |
| Content | $5.3M | 4% |
USNA
Segment breakdown not available.
